Antibiotic prophylaxis in elective thoracic surgery: cefuroxime versus cefepime

Area of Science:

• Thoracic Surgery
• Infectious Disease Prevention
• Surgical Prophylaxis

Background:

• Post-thoracic surgery infection is a significant cause of morbidity.
• Current prophylactic strategies lack definitive optimal agent, dose, or duration.
• Identifying effective prophylactic agents is crucial for patient outcomes.

Purpose of the Study:

• To compare the efficacy of cefuroxime versus cefepime in preventing surgical site infections after major thoracic surgery.
• To evaluate the impact of different prophylactic antibiotics on infection rates and complications.
• To assess the cost-effectiveness of cefuroxime compared to cefepime.

Main Methods:

• A randomized study involving 102 patients undergoing elective lung resection.
• Patients were assigned to receive either cefuroxime (n=50) or cefepime (n=52) prophylaxis.
• Infection rates, bacterial strains, empyema, and pulmonary infiltration were assessed.

Main Results:

• Significantly fewer pathogenic bacterial strains were isolated in the cefuroxime group (5) compared to the cefepime group (12) (p=0.04).
• No empyema cases occurred in the cefuroxime group, versus two in the cefepime group (p=0.16).
• Pulmonary infiltration was more frequent in the cefuroxime group (p=0.002), though overall infection rates were not statistically different (p=0.12).

Conclusions:

• Cefuroxime demonstrated marginally superior efficacy over cefepime as a prophylactic agent in major thoracic surgery.
• Cefuroxime offers a potential cost advantage in surgical prophylaxis.
• Further research may be needed to fully elucidate the benefits of cefuroxime in specific thoracic surgical contexts.